Chemoinformaics analysis of 2-(4-HEXYL-2,5-DIOXOFURAN-3-YL)ACETIC ACID
| Molecular Weight | 240.255 | nRot | 7 |
| Heavy Atom Molecular Weight | 224.127 | nRig | 12 |
| Exact Molecular Weight | 240.1 | nRing | 1 |
| Solubility: LogS | -0.394 | nHRing | 1 |
| Solubility: LogP | 0.441 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 34.7187 |
| nHD | 1 | BPOL | 20.3913 |
| QED | 0.748 |
| Synth | 2.182 |
| Natural Product Likeliness | 0.899 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.042 |
| HIA | 0.014 |
| CACO-2 | -4.569 |
| MDCK | 0.00000973 |
| BBB | 0.965 |
| PPB | 0.537417 |
| VDSS | 1.276 |
| FU | 0.460392 |
| CYP1A2-inh | 0.424 |
| CYP1A2-sub | 0.883 |
| CYP2c19-inh | 0.059 |
| CYP2c19-sub | 0.408 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.788 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.868 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.219 |
| CL | 6.676 |
| T12 | 0.862 |
| hERG | 0.022 |
| Ames | 0.037 |
| ROA | 0.028 |
| SkinSen | 0.129 |
| Carcinogencity | 0.039 |
| EI | 0.54 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.042 |
| Antiviral | Yes |
| Prediction | 0.734986 |